On Monday morning, the FDA hosted a 10-person expert panel on the use during pregnancy of SSRIs, which include medications ...

Doctors on Monday urged the U.S. Food and Drug Administration to issue warnings to pregnant women against the use of certain ...

Experts on the panel shared many of the same views around SSRIs, arguing the risks of the drugs during pregnancy are greater ...

At a recent FDA panel on SSRIs in pregnancy, the chair suggested rising antidepressant use may be contributing to — not ...

An agency-sponsored forum included critics of psychiatry who believe the drugs can harm a developing fetus. Other experts said antidepressants were safe and necessary.

A Food and Drug Administration panel on Monday discussing the use of antidepressants during pregnancy largely amounted to ...

When the U.S. Food and Drug Administration (FDA) convened a public expert panel to review the use of selective serotonin ...

Members of an FDA expert panel discussed the risks and benefits of selective serotonin reuptake inhibitors, or SSRIs, for ...

The FDA will require makers of antidepressant drugs called serotonin reuptake inhibitors (SSRIs) to include new warning labels for two possible side effects. Specifically, babies born to mothers ...

Drug makers are adding a notice to widely used antidepressants that babies of women who take the drugs late in pregnancy may experience jitteriness and other withdrawal symptoms, U.S. officials said.

FDA strengthens warning on antidepressant Paxil ... as a ``Category D'' drug for pregnant women. The classification means that studies in pregnant women have shown a risk to the fetus.

This finding supports a warning issued by the FDA during 2006 that alerted women that ... Do not stop antidepressants during pregnancy if you have become suicidal while depressed in the ...